Spinal cord stimulation (SCS) 
Introduction
Epidural spinal cord stimulation has been applied for the treatment of chronic pain for more than 40 years (1). Schlaier et al. found decreased cortical excitability during SCS in patients treated for pain (2) . To the best of our knowledge, there are only two studies where SCS has been applied with the aim to investigate the effect on epileptic seizures. In one of those studies, Ozelik et al. showed that SCS (2 Hz) had an inhibitory effect on interictal spikes induced in rats (3) . In the second study, Harreby et al. showed that low frequency SCS (4 Hz) was epileptogenic whereas higher frequency SCS (54 Hz) tended to reduce seizure susceptibility (4) . Based on that research, Harreby et al. suggested that seizures could be inhibited by SCS if a suitable SCS pattern could be established and indicated that further experiments are necessary to establish such patterns. The objective of the present work is to investigate the effect of SCS on seizure susceptibility when performed at five different stimulation frequencies ranging from 0 to 180 Hz.
Methods
All experimental procedures were approved by the Danish Animal Welfare Committee. Two male Sprague Dawley rats (250-350 g) were anesthetized using ketamine/xylazine (90/10 mg/kg). The rectal temperature was monitored and maintained within 37.5±1 ℃ using an ATC1000 Animal Temperature Controller (WPI, USA). The cervical and upper thoracic vertebrae of the animals were exposed and a custom made SCS electrode was inserted in the dorsal epidural space between C4 and C6. The rats were then placed in a stereotaxic frame and their skull was exposed through a midline incision. A hole was drilled at 2.3 mm posterior and 2.6 lateral (right) from bregma, and further extended using a rongeur. After removal of the dura, a stainless steel electrode was placed on the cortex to record the ECoG (pass -band filter = 1 Hz -4 kHz). Spike-and-wave (SW) discharges indicative of absence seizures were induced in those rats by 150 s infusion of an initial dose of 10 mg/kg/min PTZ in the femoral vein and maintained at a constant level until the end of experiments by continuous infusion of 0.21 mg/kg/min PTZ. Before PTZ administration, the SCS current was determined by gradually increasing the pulse amplitude until muscle twitches were observed near the area of the SCS electrode location. The SCS current was set immediately below the muscle activation threshold, i.e. 0.3 mA in rat 1 and 0.8 mA in rat 2. SCS was performed using charge balanced biphasic 100/500 μs pulses delivered at 0, 30, 80, 130 and 180 Hz in consecutive 60 s stimulation sessions separated by 5 min stimulation off intervals. The mentioned stimulation frequencies were randomly set by a custom made Matlab program. Four stimulation loops comprising 5 sequences of 60 s SCS with each frequency/5 min stimulation off were performed in each rat. SCS was delivered after the rats have been brought to stable SW activity by controlled PTZ infusion as described above. To confirm stimulation of the dorsal columns, the SCS-induced antidromic activation of the sural nerve was recorded using a stainless steel hook electrode placed on this nerve. At the end of the experiments, the animals were sacrificed by an overdose of anaesthesia. SCS was performed using a STG4008 stimulator (AD Instruments, Australia). All signals were recorded (PCI NIDAQ 6251, NI, USA) at 10 kHz using a custom made Matlab program. The ECoG energy was calculated as squared ECoG after filtering the raw signals (pass -band filter = 1 -200 Hz). The mean ECoG energy was calculated based on a 60 s interval and used as a measure of SW activity. In both stimulated rats, 30 Hz SCS was pro-convulsive, i.e. increased the SW amplitude from 0.7 to 1.3 mV and the SW frequency from 1.2 to 1.7 Hz. In contrast, 80 Hz SCS induced mild anti-convulsive effects and 130 Hz SCS stronger anti-convulsive effects, i.e. a decrease of the SW amplitude from 0.7 to 0.3 mV and SW frequency from 1.2 to 0.5 Hz (Fig. 1) . 180 Hz SCS induced mild effects in rat 1 and strong anti-convulsive effects in rat 2, i.e. almost total inhibition of SW discharges (Fig. 1) . ECoG energy analysis further supports the results mentioned above. Whereas 30 Hz SCS increased the ECoG energy, the other stimulation frequencies reduced the ECoG energy in a proportional manner and even almost to baseline in the case of 180 Hz SCS in rat 2 (Fig. 2) . 
Discussion
The present results indicate that epileptic SW discharges can be influenced by SCS and that the effects of SCS on SW seizures may depend on the stimulation parameters. In our SW rat seizure model, 130 Hz and 180 Hz SCS induced anti-convulsive effects and 30 Hz SCS worsened the SW activity. In addition, 180 Hz SCS only slightly influenced the SW activity when using 0.3 mA pulses, but inhibited the SW discharges almost totally when using 0.8 mA pulses, which may indicate a trend towards more effective seizure inhibition at higher current intensity. These results are consistent with our previous studies, which suggested that an SCS frequency higher than 54 Hz may have anti-convulsive effects [4] . In addition, the present results are consistent with studies investigating deep brain stimulation for epilepsy which showed that high frequency (130 Hz) stimulation of the sub-thalamic nucleus suppresses absence seizures in rats [5] . Although the data available at this moment are limited and cannot support a definitive conclusion, we consider that the present results are positive and suggest that a proper combination of SCS parameters may have antiepileptic effects. Further studies are necessary to collect more data with the investigated SCS frequencies and test several combinations of stimulation parameters in order to verify this possible outcome. If successful in acute studies, the efficiency of the method and potential side effects should be explored in a chronic animal model before testing the methods in humans 
